Taylor & Morgan Wealth Management LLC Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Taylor & Morgan Wealth Management LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 19.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 606 shares of the healthcare conglomerate’s stock after selling 143 shares during the period. Taylor & Morgan Wealth Management LLC’s holdings in UnitedHealth Group were worth $307,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. M&T Bank Corp raised its stake in shares of UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after acquiring an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC lifted its stake in UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. raised its holdings in shares of UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after buying an additional 41,308 shares during the period. Parsifal Capital Management LP purchased a new position in UnitedHealth Group during the 3rd quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC lifted its position in shares of UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after purchasing an additional 1,051 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $510.03 on Friday. The firm has a market capitalization of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company’s 50-day moving average is $549.37 and its two-hundred day moving average is $562.73. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.83 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research analyst reports. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday. Finally, Truist Financial dropped their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.